Alisporivir

Generic Name: Alisporivir

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₆₃H_₁₁₃N_₁₁O_₁₂

CAS Number: 254435-95-5

Unique Ingredient Identifier: VBP9099AA6

Background: Alisporivir has been used in trials studying the treatment of Hepatitis C and Chronic Hepatitis C.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Evaluation of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19)

Phase 2

Completed

Conditions: SARS-CoV-2

Interventions: Other: Standard of care (SOC)
Drug: Alisporivir

First Posted Date: 2020-10-29

Last Posted Date: 2023-05-11

Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Target Recruit Count: 26

Registration Number: NCT04608214

Locations: 🇫🇷
Assistance Publique Hôpitaux de Paris - CHU Henri Mondor, Créteil, France

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy